Transactions


Book Description

List of members in vol. 1-17 and occasional other volumes.




Medical Record


Book Description







Registries for Evaluating Patient Outcomes


Book Description

This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.




Medical Record


Book Description










Medicare's Histories


Book Description

Medicare is arguably Canada’s most valued social program. As federally-supported medicare enters its second half-century, Medicare’s Histories brings together leading social and health historians to reflect on the origins and evolution of medicare and the missed opportunities characterizing its past and present. Embedding medicare in the diverse constituencies that have given it existence and meaning, contributors inquire into the strengths and weaknesses of publicly insured health care and critically examine medicare’s unfinished role in achieving greater health equity for all people in Canada regardless of race, status, gender, class, age, and ability. Fundamental to the stories told in Medicare’s Histories is the essential role played by communities ¬– of activists, critics, health professionals, First Nations, patients, families, and survivors – in driving demands for health reform, in identifying particular omissions and inequities exacerbated or even created by medicare, and in responding to the realities of medicare for those who work in and rely on it. Contributors to this volume show how medicare has been shaped by politics (in the broadest sense of that word), identities, professional organizations, and social movements in Canada and abroad. As COVID lays bare social inequities and the inadequacies of health care delivery and public health, this book shows what was excluded and what was – and is – possible in health care.




When Good Drugs Go Bad


Book Description

Throughout the 1800s, opium and cocaine could be easily obtained to treat a range of ailments in Canada. Dependency, when it occurred, was considered a matter of personal vice. Near the end of the century, attitudes shifted and access to drugs became more restricted. How did this happen? Dan Malleck examines the conditions that led to Canada’s current drug laws. Drawing on newspaper accounts, medical and pharmacy journals, professional association files, asylum documents, physicians’ case books, and pharmacy records, Malleck demonstrates how a number of social, economic, and cultural forces converged in the early 1900s to influence lawmakers and criminalize addiction. His research exposes how social concerns about drug addiction had less to do with the long pipe and shadowy den than with lobbying by medical professionals, a growing pharmaceutical industry, and concern about the morality and future of the nation.